The primary site of head and neck squamous cell carcinoma predicts survival benefits of EGFR inhibitors: a systematic review and meta-analysis

CONCLUSION: Our meta-analysis suggests that the survival benefits of EGFR inhibitors might depend on primary sites in HNSCC. Further studies are needed to confirm this finding.PMID:33587969 | DOI:10.1016/j.radonc.2021.02.001

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - February 15, 2021 Category: Radiology Authors: Deheng Nie Xin Wang Meiting Sun Zhenbang Feng Fengli Pei Wenhui Liu Zonghan Wang Fujun Han Source Type: research